Publisher Full Text
MS-based methods for biomarkers of Parkinson's disease: what is the future?Bioanalysis. 2015; 7(2):149-51.B
Links
MeSH
Pub Type(s)
Editorial
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
25587831
Citation
Barkovits, Katalin, et al. "MS-based Methods for Biomarkers of Parkinson's Disease: what Is the Future?" Bioanalysis, vol. 7, no. 2, 2015, pp. 149-51.
Barkovits K, Helling S, Marcus K. MS-based methods for biomarkers of Parkinson's disease: what is the future? Bioanalysis. 2015;7(2):149-51.
Barkovits, K., Helling, S., & Marcus, K. (2015). MS-based methods for biomarkers of Parkinson's disease: what is the future? Bioanalysis, 7(2), 149-51. https://doi.org/10.4155/bio.14.273
Barkovits K, Helling S, Marcus K. MS-based Methods for Biomarkers of Parkinson's Disease: what Is the Future. Bioanalysis. 2015;7(2):149-51. PubMed PMID: 25587831.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - MS-based methods for biomarkers of Parkinson's disease: what is the future?
AU - Barkovits,Katalin,
AU - Helling,Stefan,
AU - Marcus,Katrin,
PY - 2015/1/15/entrez
PY - 2015/1/15/pubmed
PY - 2015/9/12/medline
KW - ELISA
KW - quantitative mass spectrometry
KW - synucleopathies
SP - 149
EP - 51
JF - Bioanalysis
JO - Bioanalysis
VL - 7
IS - 2
SN - 1757-6199
UR - https://www.unboundmedicine.com/medline/citation/25587831/MS_based_methods_for_biomarkers_of_Parkinson's_disease:_what_is_the_future
L2 - https://www.future-science.com/doi/abs/10.4155/bio.14.273?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -